» Articles » PMID: 142349

Quantitative Morphological Analysis of Glomerular Changes of the Rabbit Kidney on Treatment with Insulin Preparations of Different Purity

Overview
Specialty Pathology
Date 1977 Jun 23
PMID 142349
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Thirty rabbits were immunized with MC insulin and high-molecular impurities of commercial insulin preparations (a+b component) over 30, 60 and 90 days. The serum insulin antibody titer was determined in animals as the insulin binding capacity. Further, a quantitative morphological analysis of the various types of glomerular cells and of the mesangium was performed on the glomeruli as a blind study. Significant mesangial cell proliferation and an increase in mesangial matrix were found on treatment with the a+b component whereas the animals treated with MC insulin exhibited only a transient and slight mesangial activation after 30 days. There was a positive correlation between the magnitude of the insulin binding capacity and the mesangial activation. Hence, the glomerular changes which are observed after treatment with insulin which is not highly purified must be attributed to the high treatment with insulin which is not highly purified must be attributed to the high molecular weight contaminants. Heterologous pure insulin must be regarded as having virtually no immunological effect.

Citing Articles

Glomerular structural changes in rabbits on treatment with bovine and porcine insulin. A morphometric analysis.

Wehner H, Eiche T, Eiche F, Heding L Virchows Arch A Pathol Anat Histol. 1980; 389(2):211-23.

PMID: 7006198 DOI: 10.1007/BF00439487.

References
1.
CHANCE R, Ellis R . Proinsulin. Single-chain precursor of insulin. Arch Intern Med. 1969; 123(3):229-36. DOI: 10.1001/archinte.123.3.229. View

2.
Olsen S . Mesangial thickening and nodular glomerular sclerosis in diabetes mellitus and other diseases. Acta Pathol Microbiol Scand Suppl. 1972; 233:203-16. View

3.
KORP W, LEVETT R . [Experiences with monocomponent insulin treatment]. Wien Klin Wochenschr. 1973; 85(18):326-30. View

4.
Melani F, Rubenstein A, Steiner D . Human serum proinsulin. J Clin Invest. 1970; 49(3):497-507. PMC: 322497. DOI: 10.1172/JCI106259. View

5.
Andreani D, Iavicoli M, Colletti A, Menzinger G . [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type]. Folia Endocrinol. 1972; 25(6):516-39. View